G01N 2440/16
Amidation
Official title: (de-)amidation
G01N2440/16 (Amidation) appears on 4 US grants and 10 published applications in this corpus.
Search patents in G01N- Granted patents
- 4
- Published applications
- 10
- Assignees
- 14
- Inventors
- 35
- Latest grant
- 21 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2016 | 0 | 2 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 1 | 2 |
| 2020 | 1 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 1 |
| 2023 | 0 | 1 |
| 2024 | 0 | 1 |
| 2025 | 1 | 0 |
| 2026 | 1 | 3 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Biochemical medical diagnostic kit21 Jul 2026US 12,687,547 B2
- Double deamidated form of Bcl-xL is a biomarker of platelet age11 Nov 2025US 12,467,924 B2Centre National De La Recherche Scientifique
- Method to detect autoantibody reactivity for deamidated insulin autoantigen in diabetes25 Feb 2020US 10,570,185 B2Northwestern University
- Compositions and methods for analysis of protein sequences and post-translational modifications7 May 2019US 10,281,473 B2University of Virginia Patent Foundation
- Deamidation determination using direct infusion mass spectrometry6 Aug 2026US 2026/0229474 A1
- Biomolecule analysis by fluorescence intermittence signal recognition9 Jul 2026US 2026/0194529 A1UniversitäT ZüRich
- Rapid deamidation screening7 May 2026US 2026/0126375 A1Protein Dynamic Solutions, Inc.
- Biochemical medical diagnostic kit4 Apr 2024US 2024/0110923 A1Argeron Medikal Arastirma Sanayi Ve Ticaret Anonim Sirketi
- Methods of processing a sample for peptide mapping analysis2 Nov 2023US 2023/0349912 A1Amgen Inc.
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.